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Obstetricians–gynecologistsThe Affordable Care Act (ACA) requires states to provide tobacco-cessation services without cost-sharing for
pregnant traditional Medicaid-beneﬁciaries effective October 2010. It is unknown the extent to which obstetri-
cians–gynecologists are aware of the Medicaid tobacco-cessation beneﬁt. We sought to examine the awareness
of the Medicaid tobacco-cessation beneﬁt in a national sample of obstetricians–gynecologists and assessed
whether reimbursement would inﬂuence their tobacco cessation practice. In 2012, a survey was administered
to a national stratiﬁed-random sample of obstetricians–gynecologists (n = 252) regarding awareness of the
Medicaid tobacco-cessation beneﬁt. Results were stratiﬁed by the percentage of pregnant Medicaid patients.
Chi-squared tests (p b 0.05) were used to assess signiﬁcant associations. Analyses were conducted in 2014.
Eighty-three percent of respondents were unaware of the beneﬁt. Lack of awareness increased as the percentage
of pregnantMedicaid patients in their practices decreased (range=71.9%–96.8%; P=0.02). One-third (36.1%) of
respondents serving pregnantMedicaid patients reported that reimbursement would inﬂuence them to increase
their cessation services. Four out of ﬁve obstetricians–gynecologists surveyed in 2012 were unaware of the ACA
provision that required states to provide tobacco cessation coverage for pregnant traditional Medicaid beneﬁcia-
ries as of October 2010. Broad promotion of the Medicaid tobacco-cessation beneﬁt could reduce treatment
barriers.
Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Tobacco use during pregnancy is the most common cause of pre-
ventable poor infant outcomes (e.g., pretermdelivery, lowbirthweight)
for which effective interventions exist (Chamberlain et al., 2013;
USDHHS, 2014). In addition, prenatal smoking is associated with an es-
timated $122million in excess infant health care costs at delivery in the
United States (Adams et al., 2011). Signiﬁcant disparities exist between
low and high socioeconomic status women, particularly amongwomen
enrolled in Medicaid. Smoking prevalence during and after pregnancy
was 17.6% and 23.4%, respectively, among Medicaid enrolled women
versus 5.2% and 9.3% among privately insured women (Tong et al.,
2013). Considering thatMedicaid is the largest payer of prenatal and de-
livery healthcare and covers 45% of US births (TheHenry J. Kaiser Family
Foundation, 2014), the potential cost-savings of eliminating tobacco use
and averting poor birth outcomes in the pregnant Medicaid population
could be substantial (Adams et al., 2011; Lightwood et al., 1999).Health/NCCDPHP, Centers for
S-F74, Atlanta, GA 30341, USA.
ss article under the CC BY license (htThe Affordable Care Act (ACA) requires states to provide tobacco-
cessation services, including counseling and pharmacotherapy, without
cost-sharing (i.e., no out-of-pocket costs) for pregnant traditional
Medicaid beneﬁciaries effective October 2010 (USDHHS, 2011).
However, it is unknown the extent to which obstetricians–gynecologists
are aware of the Medicaid tobacco-cessation beneﬁt. We examined
awareness of the Medicaid tobacco-cessation beneﬁt in a national
sample of obstetricians–gynecologists and assessed whether reim-
bursement would inﬂuence their cessation practice. These ﬁndings
can be useful to inform state maternal and child health and tobacco
control efforts to reduce prenatal smoking.
Methods
During February–August 2012, the American College of Obstetri-
cians and Gynecologists (ACOG) conducted a mailed survey of a national
stratiﬁed-random sample of practicing obstetricians–gynecologists. De-
tailed methodology has been described previously (Coleman-Cowger
et al., 2014). Brieﬂy, 425 Collaborative Ambulatory Research Network
(CARN) and 599 non-CARN members were invited to participate.
CARNmembers are clinicianswho volunteer to participate in ACOG sur-
veys. Those invited received an introductory letter and up to 3tp://creativecommons.org/licenses/by/4.0/).
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sample was further restricted to clinicians providing obstetrical care
(n= 252, 62% of respondents). The studywas deemed exempt from re-
view by ACOG and the Centers for Disease Control and Prevention Insti-
tutional Review Boards.
The survey focused on practice patterns and opinions related to pa-
tient tobacco use. The two survey questions analyzed for this study
were: 1) “Are you aware that the ACA includes a provision that requires
that pregnant women onMedicaid receive coverage for comprehensive
smoking cessation services, including both counseling and pharmaco-
therapy?”; 2) “Howmuch inﬂuencewould reimbursement for cessation
services for pregnant women on Medicaid under the ACA have on how
you provide cessation services?” Results were stratiﬁed by the categor-
ical response of the percentage of pregnant Medicaid patients seen by
respondents (0, 1–24%, 25–50%, N50%). Chi-squared tests (p b 0.05)
were used to assess signiﬁcant associations. Analyses were conducted
in 2014.
Results
The majority of respondents were female (55.8%) and non-Hispanic
White (84.3%); on average, respondents completed residency 19 years
ago. Most respondents practiced in urban/suburban locations (81.0%),
and 30.6% provided comprehensive primary care for women. About a
quarter of respondents had N50% pregnant Medicaid patients; 61.6%
had b50% pregnant Medicaid patients; and 13.2% had no pregnant
Medicaid patients (Table 1).
Overall, 83% of obstetricians–gynecologists were unaware of the
Medicaid tobacco-cessation beneﬁt for pregnant patients. Lack of
awareness increased as the percentage of pregnant Medicaid
patients in their practices decreased (range = 71.9%–96.8%; P =
0.02) (Table 1). Of respondents who saw pregnant Medicaid pa-
tients, one-third (36.1%) said reimbursement would increase their
cessation services, and nearly 40% of those with N50% Medicaid pa-
tients said they would increase their services. A substantial fraction
(30.2%) of respondents reported that cessation services would not
change because reimbursement wouldn't address ‘existing barriers
to delivering service’, and 16.2% said they did not know how reim-
bursement would affect their cessation practices.
Discussion
We found that 4 out of 5 obstetricians–gynecologists surveyed in
2012were unaware of the ACAprovision that required states to provide
tobacco cessation coverage for pregnant traditional Medicaid beneﬁcia-
ries. However, one-third of respondents reported that reimbursement
would inﬂuence them to increase cessation services, and an evenTable 1
Obstetricians–gynecologists' awareness of Medicaid tobacco-cessation beneﬁt for pregnant pat
Total
Awareness of Medicaid tobacco-cessation beneﬁt for pregnant women
Yes
No
Will ACA provision inﬂuence reimbursement for cessation services?b
It won't change how I provide services because our services are already adequate
It won't change how I provide services as it won't address existing barriers to
delivering service
It won't change for other reasons
I will likely increase our services because of improvement in reimbursement
I will likely increase our services for other reasons
I don't know
ACA = Affordable Care Act.
a Based on chi-square tests.
b Respondents (n = 202) could only mark one response.greater percentage was seen among respondents who saw more
Medicaid-enrolled patients. A previous study suggests that states with
more comprehensive Medicaid coverage of tobacco cessation treat-
ments, primarily through coverage of medications, resulted in 1.6
percentage point reduction (p b .05) in smoking before pregnancy
and a small increase (b1 day) in infant gestation (Adams et al.,
2013). In addition, as counseling will also be covered by the ACA
mandate, a meta-analysis of 77 trials found that psychosocial inter-
ventions are effective in increasing the proportion of women who
stop smoking in late pregnancy, andwomenwho received psychoso-
cial interventions had an 18% reduction in preterm births and infants
born low birth weight (Chamberlain et al., 2013). Hence, reducing
barriers to cessation treatments, as such through a comprehensive
tobacco cessation beneﬁt, could potentially allow more smokers to
access treatment, increase cessation and improve infant outcomes
among pregnant Medicaid enrollees.
Comprehensive and well-publicized beneﬁts have shown larger ef-
fects in quitting among the general population of Medicaid-enrollees
in the state of Massachusetts, including among young people and
women (Land et al., 2010). For providers, this promotion included the
development of fact sheets,with rate and billing codes, a pharmacother-
apy pocket guide, and new intake and assessment protocols that were
widely disseminated to health care systems and facilities (CDC, 2014).
In addition, the state also directed educational campaigns to consumers,
tracked the use of the beneﬁts, and provided feedback and recognition
to providers who were regularly referring patients. Acknowledging
the importance of raising awareness of the tobacco cessation beneﬁt,
the Centers for Medicare and Medicaid Services placed information on
their website (Centers for Medicare and Medicaid Services, 2014)
about Medicaid tobacco-cessation beneﬁts for pregnant women and
non-pregnant enrollees (Singleterry et al., 2014). However, broad
state promotion and outreach of the Medicaid tobacco-cessation bene-
ﬁts, as noted earlier, for pregnantwomen can help to increase treatment
utilization.
A substantial percentage of respondents reported that reimburse-
ment would be insufﬁcient to address existing barriers for cessation.
Provider barriers that have been reported in a previous analysis of this
data included time limitations to deliver cessation services in prenatal
care visits and patient's resistance to intervention (Coleman-Cowger
et al., 2014). While reimbursement may improve service provision
and broadpromotion of the beneﬁtsmay increase awareness, additional
strategies, such as provider training (Tong et al., 2012) and healthcare
system changes to facilitate stream-lined screening and treatment
(Fiore et al., 2008), are also important to increase treatment utilization.
Educational campaigns directed to consumers could also stress the im-
portance and/or beneﬁts of quitting smoking and support that prenatal
care staff can provide.ients covered by Medicaid (n = 252).
Total
%
Percent of pregnant patients covered by Medicaid
0% 1–24% 25–50% N50% p-Valuea
100.0% 13.2% 30.2% 31.4% 25.2%
17.0% 3.2% 15.3% 16.0% 28.1% 0.02
83.0% 96.8% 84.7% 84.0% 71.9%
7.4% NA 15.5% 1.4% 5.2% 0.09
30.2% NA 29.6% 32.9% 27.6%
5.4% NA 5.6% 2.7% 8.6%
36.1% NA 31.0% 38.4% 39.7%
4.5% NA 1.4% 6.8% 5.2%
16.3% NA 16.9% 17.8% 13.8%
688 V.T. Tong et al. / Preventive Medicine Reports 2 (2015) 686–688This study has limitations to note. First, the study is limited by the
low survey response rates (31–52%), which is consistent with previ-
ous ACOG surveys. However, nonresponse bias has been shown to
be minimal among physician groups compared to other groups
(Kellerman and Herold, 2001). Second, the sample size is small. For
our analysis of how reimbursement would inﬂuence cessation ser-
vices, we had limited power to test for differences in whether reim-
bursement would inﬂuence cessation services by percentage of
Medicaid patients seen. Finally, these data are self-reported, and
we did not verify information regarding awareness with their actual
cessation or billing practices.
In conclusion, four out of ﬁve obstetricians–gynecologists surveyed
in 2012 were unaware of the ACA provision that required states to
provide tobacco cessation coverage for pregnant traditional Medicaid
beneﬁciaries, and a third of respondents serving pregnant Medicaid
patients reported that reimbursement would inﬂuence them to in-
crease their cessation services. Promoting awareness of the Medicaid
tobacco-cessation beneﬁt among all medical providers who see preg-
nant and reproductive-aged women could help to reduce treatment
barriers, thereby increasing cessation and improving maternal and in-
fant health.
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